ThermoCool SF NAV BNI35BDCTRecalls & reported problems
Biosense Webster Inc · Class 3
All models of ThermoCool SF NAV (17)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 1
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 10846835003147), received between Oct 31, 2016 and Jul 21, 2022 — classified as 1 death, 3 injuries, 2 malfunctions.
The most frequently reported specific device problem is “Material Protrusion/Extrusion” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem3
- Material Protrusion/Extrusion1
- Material Twisted/Bent1
- Patient Device Interaction Problem1
- Tear, Rip or Hole in Device Packaging1
Patient problems
- Cardiac Tamponade3
- Aortic Dissection1
- Death1
- No Clinical Signs, Symptoms or Conditions1
- No Code Available1
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
MalfunctionJul 21, 2022Material Protrusion/Extrusion; Material Twisted/Bent; Material Protrusion/Extrusion; Material Twisted/Bent
IT WAS REPORTED THAT A PATIENT UNDERWENT A SUPRAVENTRICULAR TACHYCARDIA (SVT) ABLATION PROCEDURE WITH A THERMOCOOL® SF NAV BI-DIRECTIONAL CATHETER AND AN INTERNAL COMPONENTS EXPOSED ISSUE OCCURRED. WHEN THE CATHETER WAS REMOVED FROM THE PACKAGING, IT WAS NOTICED THAT THERE WAS A BEND TOWARDS THE DISTAL TIP OF THE CATHETER. IT WAS OBSERVED THAT A WIRE WAS SHOWING NEAR THE DISTAL IVC ELECTRODE. THE DAMAGE DID NOT RESULT IN ANY LIFTED OR SHARP RINGS. THE CATHETER WAS REPLACED, THE ISSUE RESOLVED AND THE PROCEDURE CONTINUED. NO ADVERSE PATIENT CONSEQUENCE WAS REPORTED. THE BEND AT THE DISTAL TIP OF THE CATHETER WAS ASSESSED AS NOT MDR REPORTABLE. THE INTERNAL COMPONENTS EXPOSED ISSUE WAS ASSESSED AS A MDR REPORTABLE PRODUCT MALFUNCTION.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15071584 ↗InjuryNov 29, 2020Patient Device Interaction Problem; Patient Device Interaction Problem
IT WAS REPORTED THAT A FEMALE PATIENT UNDERWENT CARDIAC ABLATION PROCEDURE FOR ATRIAL FIBRILLATION (AFIB) WITH THERMOCOOL® SF NAV BI-DIRECTIONAL CATHETER AND SUFFERED CARDIAC TAMPONADE REQUIRING PERICARDIOCENTESIS. IT WAS REPORTED WHILE THE PATIENT WAS IN THE RECOVERY ROOM AFTER THE PROCEDURE; THE PATIENT APPEARED VERY GRAY, PALE, AND HER BLOOD PRESSURE DROPPED. THE PATIENT WAS TAKEN BACK TO THE PROCEDURE ROOM AND THE PATIENT HAD AN ULTRASOUND THAT CONFIRMED THE PATIENT HAD A PERICARDIAL EFFUSION. PERICARDIOCENTESIS WAS PERFORMED. THE PATIENT WAS STABLE AND WAS TRANSFERRED TO THE CARDIAC INTENSIVE CARE UNIT FOR OVERNIGHT OBSERVATION. THERE WAS NO REPORT OF EXTENDED HOSPITALIZATION. PHYSICIAN¿S CAUSALITY OPINION WAS NOT PROVIDED. TRANSSEPTAL WAS PERFORMED WITH A BRK NEEDLE (ST. JUDE). ABLATION WAS PERFORMED BEFORE THE EVENT. THERE WAS NO EVIDENCE OF STEAM POP. FLOW SETTINGS WERE USED PER THE INSTRUCTIONS FOR USE GUIDELINES. NO ERROR MESSAGES WERE OBSERVED ON THE BIOSENSE WEBSTER EQUIPMENT DURING THE PROCEDURE.
Patient problems: Cardiac Tamponade
MAUDE report 10916287 ↗InjuryApr 23, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A FEMALE PATIENT UNDERWENT AN ATRIAL FIBRILLATION (AFIB) ABLATION PROCEDURE WITH A THERMOCOOL® SF NAV BI-DIRECTIONAL CATHETER AND SUFFERED CARDIAC TAMPONADE REQUIRING PERICARDIOCENTESIS AND SURGICAL INTERVENTION. POST-PROCEDURE (APPROXIMATELY 20-30 MINUTES), THE PATIENT COMPLAINED ABOUT CHEST PAIN. CARDIAC TAMPONADE WAS CONFIRMED BY ECHO. PERICARDIOCENTESIS WAS PERFORMED TO REMOVE AN UNSPECIFIED AMOUNT OF FLUID FROM THE PERICARDIUM. THE PATIENT WAS TRANSFERRED TO THE OPERATING ROOM WHERE PATIENT¿S CHEST WAS OPENED, AND STITCHES WERE PLACED TO REPAIR THE PERFORATION. EXTENDED HOSPITALIZATION WAS REQUIRED AS A RESULT OF THE EVENT. PATIENT¿S OUTCOME IS IMPROVED. THE PHYSICIAN DID NOT PROVIDE A CAUSALITY OPINION. TRANSSEPTAL PUNCTURE WAS PERFORMED WITH A BRK-1 TRANSSEPTAL NEEDLE. TWO SL-1 SHEATHS WERE USED DURING THE CASE. THE GENERATOR WAS USED WITH DEFAULT SETTINGS IN POWER CONTROL MODE. THE PHYSICIAN ABLATED 35 WATTS ON RIDGE/ANTERIOR WALL AND 25 WATTS ON POSTERIOR WALL. THE CATHETER IRRIGATION WAS USED WITH DEFAULT SETTINGS. NO ERROR MESSAGES WERE OBSERVED ON ANY BWI EQUIPMENT DURING THE PROCEDURE.
Patient problems: Cardiac Tamponade; No Code Available
MAUDE report 8540741 ↗MalfunctionDec 12, 2018Tear, Rip or Hole in Device Packaging; Tear, Rip or Hole in Device Packaging
IT WAS REPORTED THAT A PATIENT UNDERWENT AN ABLATION PROCEDURE FOR ATRIAL FIBRILLATION (AFIB) WITH A THERMOCOOL® SF NAV BI-DIRECTIONAL CATHETER AND A PACKAGING ISSUE OCCURRED. THE AREA WHERE THE PACKAGE SEALS DID NOT LOOK COMPLETELY SEALED. THE THERMOCOOL® SF NAV BI-DIRECTIONAL CATHETER WAS PULLED OUT OF THE BOX AND INSPECTED AND THE PHYSICIAN DIDN'T FEEL COMFORTABLE USING IT. PACKAGING WAS COMPLETELY OPENED BUT THE CATHETER WAS NEVER USED. NO ADVERSE PATIENT CONSEQUENCES WERE REPORTED. THE PACKAGING ISSUE HAS BEEN ASSESSED AS MDR REPORTABLE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8157199 ↗InjurySep 24, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A (B)(6) PATIENT UNDERWENT AN ATRIAL FIBRILLATION (AFIB) ABLATION PROCEDURE WITH AN THERMOCOOL® SF NAV BI-DIRECTIONAL CATHETER AND SUFFERED CARDIAC TAMPONADE REQUIRING PERICARDIOCENTESIS. DURING ABLATION PHASE, PERICARDIAL EFFUSION WAS DISCOVERED BY FLUORO. CARDIAC TAMPONADE WAS CONFIRMED BY TRANSTHORACIC ECHO (TEE). PERICARDIOCENTESIS WAS PERFORMED TO REMOVE 500CC OF FLUID FROM THE PERICARDIUM. THE PATIENT WAS REPORTED TO BE IN STABLE CONDITION AFTER PERICARDIAL DRAINAGE. IT IS UNKNOWN IF EXTENDED HOSPITALIZATION WAS REQUIRED AS A RESULT OF THE ADVERSE EVENT. PATIENT¿S OUTCOME IS IMPROVED. PHYSICIAN¿S OPINION REGARDING THE CAUSE OF THE ADVERSE EVENT IS THAT IT WAS PATIENT CONDITION-RELATED. THERE WERE NO ERROR MESSAGES OBSERVED ON ANY BWI EQUIPMENT DURING THE PROCEDURE. PATIENT¿S RELEVANT HISTORY INCLUDES METASTATIC CANCER. TRANSSEPTAL PUNCTURE WAS NOT PERFORMED. A BARD SL1 8.5FR SHEATH WAS USED DURING THE PROCEDURE. THERE¿S NO INFORMATION REGARDING ABLATION PARAMETERS. THE CATHETER IRRIGATION FLOW RANGED FROM 8/15ML/MIN. THE PATIENT DID NOT RECEIVE ANTICOAGULANT DURING THE PROCEDURE.
Patient problems: Cardiac Tamponade
MAUDE report 7902610 ↗DeathOct 31, 2016Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A (B)(6) FEMALE PATIENT UNDERWENT AN IDIOPATHIC LEFT VENTRICULAR TACHYCARDIA ABLATION PROCEDURE FOR PREMATURE VENTRICULAR CONTRACTIONS AND PERSISTENT ATRIAL FIBRILLATION WITH AN EZ STEER THERMOCOOL SF NAV CATHETER AND SUFFERED A VASCULAR DISSECTION RESULTING IN THE PATIENT'S DEATH. DURING THE PROCEDURE, THE PATIENT DEVELOPED AN AORTIC DISSECTION. PATIENT WAS TAKEN TO THE OPERATING ROOM FOR SURGICAL REPAIR OF THE AORTA. PATIENT EXPIRED DURING SURGICAL PREPARATION. THERE IS NO INFORMATION REGARDING AN AUTOPSY. PHYSICIAN'S OPINION REGARDING THE CAUSE OF DEATH IS THAT IT WAS SECONDARY TO AN AORTIC DISSECTION THAT OCCURRED WHILE CROSSING THE VALVE WITH THE ABLATION CATHETER.
Patient problems: Aortic Dissection; Death
MAUDE report 6068199 ↗
Other catheter, percutaneous, cardiac ablation, for treatment of atrial flutter devices
- QDOT MICRO D139505Biosense Webster Inc · catheter, percutaneous, cardiac ablation, for treatment of atrial flutter27 deaths915 reports
- IntellaNav MiFi™ Open-Irrigated M004PMR96200Boston Scientific Corporation · catheter, percutaneous, cardiac ablation, for treatment of atrial flutter4 deaths269 reports
- QDOT MICRO D139504Biosense Webster Inc · catheter, percutaneous, cardiac ablation, for treatment of atrial flutter7 deaths138 reports
- Sphere-9™ Catheter AFR-00001Medtronic, Inc. · catheter, percutaneous, cardiac ablation, for treatment of atrial flutter1 recall5 deaths77 reports
- QDOT MICRO D139401Biosense Webster Inc · catheter, percutaneous, cardiac ablation, for treatment of atrial flutter2 deaths114 reports
- NaviStar ThermoCool NI75TCDHBiosense Webster Inc · catheter, percutaneous, cardiac ablation, for treatment of atrial flutter111 reports
- NaviStar RMT ThermoCool NR7TCSIYBiosense Webster Inc · catheter, percutaneous, cardiac ablation, for treatment of atrial flutter9 deaths103 reports
- IntellaNav MiFi™ Open-Irrigated M004PMR9620K20Boston Scientific Corporation · catheter, percutaneous, cardiac ablation, for treatment of atrial flutter78 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page